Clinical factors associated with long-term survival in metastatic melanoma treated with anti-pd1 alone or in combination with ipilimumab
HIGHLIGHTS who: Siddhartha Goutam and collaborators from the Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T G […]